Company intelligence / Profile preview

Suzhou Zanrong Pharmaceutical Technology Co. Ltd.

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Suzhou Zanrong Pharmaceutical Technology Co. Ltd., established in 2018 and based in Hong Kong with R&D centers in Shanghai and Suzhou, is a clinical-stage biotech company developing innovative small-molecule oncology drugs. The company focuses on differentiated "best-in-class" and "first-in-class" therapeutics targeting substantial unmet needs in oncology—especially brain metastases from HER2-positive breast cancer. Its lead program ZN-A‑1041 is an oral HER2 inhibitor designed to cross the blood-brain barrier; it has reached Phase I trials and was globally licensed to Roche for further development and commercialization. Another pipeline asset targets ATM for advanced solid tumors.

Therapeutic areas: Oncology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

3 assets

ZN-F-6418

2 more assets in the full pipeline.

Partnerships

Roche – exclusive global licensing agreement for ZN-A‑1041 as of May 2023.

Beyond the preview

Go deeper on Suzhou Zanrong Pharmaceutical Technology Co. Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suzhou Zanrong Pharmaceutical Technology Co. Ltd..